Hypertension, PulmonaryHypertensionPulmonary ArteryHypertrophy, Right VentricularMonocrotalineBlood PressurePersistent Fetal Circulation SyndromeHypertension, PortalAntihypertensive AgentsHypertension, RenalPulmonary CirculationAnoxiaSurvival RateHypertension, RenovascularHemodynamicsVascular ResistanceHypertension, MalignantLungCell SurvivalPulmonary Wedge PressurePulmonary EmbolismIdiopathic Pulmonary FibrosisVentricular Function, RightVasodilator AgentsIloprostTreatment OutcomeRisk FactorsSulfonesBone Morphogenetic Protein Receptors, Type IIVentricular Dysfunction, RightEpoprostenolChronic DiseaseTime FactorsRetrospective StudiesHypertension, Pregnancy-InducedFollow-Up StudiesDisease Models, AnimalEndarterectomyPurinesNitric OxideCardiac CatheterizationEndothelin-1Ocular HypertensionPhosphodiesterase 5 InhibitorsProspective StudiesDisease-Free SurvivalSurvival AnalysisAdministration, InhalationIntracranial HypertensionRats, Sprague-DawleyBlood Pressure DeterminationPregnancy Complications, CardiovascularRats, Inbred SHRReninPoisonsEchocardiographyKidneyArterial PressurePrevalenceSeverity of Illness IndexSurvivalEchocardiography, DopplerVasoconstrictionMuscle, Smooth, VascularPrognosisRats, Inbred WKYCohort StudiesPseudotumor CerebriReceptors, EndothelinPiperazinesPulmonary FibrosisPulmonary Veno-Occlusive DiseaseScleroderma, SystemicCyclic Nucleotide Phosphodiesterases, Type 5SystoleCase-Control StudiesPulmonary Heart DiseaseCardiac OutputDesoxycorticosteronePhosphodiesterase InhibitorsGraft SurvivalAge FactorsScoliosisEndothelium, VascularRenin-Angiotensin SystemNitric Oxide Synthase Type IIIAngiotensin IISodium Chloride, DietaryBlood Pressure Monitoring, AmbulatoryVasodilationHeart RateHeart VentriclesThromboembolismArthritis, JuvenileDiureticsInfant, NewbornRisk AssessmentProstaglandins IPredictive Value of TestsDisease Progression